PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-145 Cr | ₹-157 Cr | ₹-130 Cr | ₹-105 Cr | ₹-22 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-145 Cr |
| Mar2024 | ₹-157 Cr |
| Mar2023 | ₹-130 Cr |
| Mar2022 | ₹-105 Cr |
| Mar2021 | ₹-22 Cr |
How is Deferred Tax Assets / Liabilities of PIRAMAL PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-145 Cr | Negative | |
| Mar2024 | ₹-157 Cr | Negative | |
| Mar2023 | ₹-130 Cr | Negative | |
| Mar2022 | ₹-105 Cr | Negative | |
| Mar2021 | ₹-22 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹21,685.9 Cr | 3.6% | -2.2% | -29.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 0.5% | -1.5% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 5.5% | -0.2% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | 1.3% | -7.9% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2% | 4.5% | 2.3% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 3.6% |
-2.2% |
-29.1% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses